| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 09/16/1999 | CA2322618A1 Methods of diagnosis and triage using cell activation measures |
| 09/15/1999 | EP0941125A1 Methods for regulating angiogenesis |
| 09/15/1999 | EP0941110A1 Uses of keratinocyte growth factor-2 |
| 09/15/1999 | EP0941108A1 Wound healing and treatment of fibrosis |
| 09/15/1999 | EP0941094A1 Process for manufacturing ophthalmic suspensions |
| 09/15/1999 | EP0941080A2 Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
| 09/15/1999 | EP0799188B1 Amides of mono and dicarboxylic acids with glycosamines, selectively active on the cannabinoid peripheral receptor |
| 09/15/1999 | EP0741697B1 Amino acid derivatives and their use as phospholipase a2 inhibitors |
| 09/15/1999 | EP0656001B1 Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
| 09/15/1999 | CN1228780A Phosphinic acid amides as matrix metalloprotease inhibitors |
| 09/15/1999 | CN1228779A Spirocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228775A Benzofurans and benzopyrans as chronobiological agents |
| 09/15/1999 | CN1228773A Heterocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228772A Heterocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228771A 1,3-diheterocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228767A Bidentate metalloprotease inhibitors |
| 09/15/1999 | CN1228710A Pharmaceutical composition containing lornoxicam and disodic salt of EDTA |
| 09/15/1999 | CN1228707A Titanium slow-release composition |
| 09/15/1999 | CN1228697A Method for in vivo reduction of iron levels and compositions useful therefor |
| 09/15/1999 | CN1228306A Eye drops for curing electric ophthalimia |
| 09/14/1999 | US5952382 Inhibiting the biological effects of an overregulation of retinoid acid receptors and/or of a hypervitaminosis a; treating skin disorder, eye vision defects, skin aging |
| 09/14/1999 | US5952381 Para-substituted phenylene derivatives |
| 09/14/1999 | US5952378 Methods and means for drug administration |
| 09/14/1999 | US5952362 2-imidazoline, 2-oxazoline, 2-thiazoline, and 4-imidazole derivatives of methylphenyl, methoxyphenyl, and aminophenyl alkylsulfonamides and ureas and their use |
| 09/14/1999 | US5952322 Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors |
| 09/14/1999 | US5951971 Eye-drops for treatment of eye disorders and surrounding area comprising cyclosporin and surfactant selected from polyoxyethylene fatty acid esters, polyoxyethylene alkylphenol ether and polyoxyethylene alkyl ethers |
| 09/10/1999 | WO1999045006A1 Heterocyclic compounds as inhibitors of rotamase enzymes |
| 09/10/1999 | WO1999044989A1 Matrix metalloproteinase inhibitors |
| 09/10/1999 | WO1999044624A2 Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy |
| 09/10/1999 | WO1999044613A1 Pharmaceutical compositions containing in combination two antagonists selective of arginine-vassopressin v receptors, even of v1a and v2 receptors |
| 09/10/1999 | WO1999021617B1 Allosteric adenosine receptor modulators |
| 09/10/1999 | CA2322854A1 Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy |
| 09/10/1999 | CA2322442A1 Heterocyclic compounds as inhibitors of rotamase enzymes |
| 09/10/1999 | CA2317502A1 Matrix metalloproteinase inhibitors |
| 09/08/1999 | EP0940391A2 Quinoline derivatives as tachykinin NK3 receptor antagonists |
| 09/08/1999 | EP0939757A1 Novel integrin receptor antagonists |
| 09/08/1999 | EP0939635A1 Improved intraocular irrigating solution containing a polyamine antagonist |
| 09/08/1999 | EP0939631A1 Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms |
| 09/08/1999 | EP0939629A1 Thiol sulfonamide metalloprotease inhibitors |
| 09/07/1999 | US5948804 Anaesthetic premedication |
| 09/07/1999 | US5948768 Treatment of otitis media by sublingual administration of DNA |
| 09/07/1999 | US5948657 Phenylalanyl-tRNA synthetase from Staphylococcus aureus |
| 09/07/1999 | US5948402 Method of using IL-11 for treating antibiotic induced diarrhea |
| 09/07/1999 | CA2098944C Novel pyrazole derivatives, method of preparing them and pharmaceutical compositions in which they are present |
| 09/07/1999 | CA2014008C Benzimidazoles, medicaments containing these compounds and processes for their preparation |
| 09/02/1999 | WO1999043657A1 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists |
| 09/02/1999 | WO1999043652A1 Indole derivatives and medicinal compositions containing the same |
| 09/02/1999 | WO1999043347A1 Remedies for corneal epithelium disturbance |
| 09/02/1999 | WO1999032158A3 Aminobiguanides to disinfect contact lenses and preserve pharmaceutical compositions |
| 09/02/1999 | WO1999023105A9 Vegi, an inhibitor of angiogenesis and tumor growth |
| 09/02/1999 | CA2321704A1 Remedies for corneal epithelium disturbance |
| 09/01/1999 | EP0939123A2 Estrogen receptor-related polypetide SBPERR4 |
| 09/01/1999 | EP0938896A1 Autoclavable pharmaceutical compositions containing a chelating agent |
| 09/01/1999 | EP0938881A1 Collagen-base auxiliary agent for ophthalmic surgery |
| 09/01/1999 | EP0938472A2 15-fluoro prostaglandins as ocular hypotensives |
| 09/01/1999 | EP0938471A1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 09/01/1999 | EP0938328A1 Method of inhibiting fibrosis with a somatostatin agonist |
| 09/01/1999 | EP0938309A1 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 09/01/1999 | EP0700301B1 Peptides and compounds that bind to elam-1 |
| 09/01/1999 | EP0672055B1 Neuropeptide y antagonists |
| 09/01/1999 | CN1227540A Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 09/01/1999 | CN1227225A Thiazole derivatives |
| 08/31/1999 | US5945398 In a hydrophilic carrier comprising propylene glycol,esterification product of vegetable oil triglyceride and polyalkalene glycol polyol and polyoxyethylene hydrogenated castor oil; free-flowing, clear, transparent |
| 08/31/1999 | US5945302 Nucleotide sequences that code for proteins for use in recombinant technology, induce production of cytokines, activate cell differentiation, stimulate and suppress immune responses, and therapy for autoimmune diseases |
| 08/26/1999 | WO1999042443A1 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases |
| 08/26/1999 | WO1999042436A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 08/26/1999 | WO1999042104A1 Use of macrolide compounds for treating glaucoma |
| 08/26/1999 | WO1999042088A2 Method for the treatment of diseases or disorders of the inner ear |
| 08/26/1999 | WO1999028475A9 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 08/26/1999 | WO1999024421A8 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom |
| 08/26/1999 | CA2320469A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 08/25/1999 | EP0937069A1 Piperazino derivatives as neurokinin antagonists |
| 08/25/1999 | EP0937065A1 Constrained somatostatin agonists and antagonists |
| 08/25/1999 | EP0937045A1 N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity |
| 08/25/1999 | EP0937036A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors |
| 08/25/1999 | EP0937030A1 3-amino-propoxyphenyl derivatives (i) |
| 08/24/1999 | US5942487 Composition for treating cornea |
| 08/24/1999 | US5942419 RsbW-1 encoding nucleic acids |
| 08/24/1999 | US5942251 Pharmaceutical compositions for intranasal administration of dihydroergotamine |
| 08/24/1999 | CA2180944C Method for delipidation of skin and cerumen removal |
| 08/24/1999 | CA2147126C Piperidine derivatives and process for their production |
| 08/19/1999 | WO1999041282A1 Therapeutic uses of keratinocyte growth factor-2 |
| 08/19/1999 | WO1999041246A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors |
| 08/19/1999 | WO1999041224A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors |
| 08/19/1999 | WO1999040933A1 Use of hyaluronidase to reduce viscoelastic related increases in intraocular pressure |
| 08/19/1999 | WO1999024024A3 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists |
| 08/19/1999 | CA2320515A1 Therapeutic uses of keratinocyte growth factor-2 |
| 08/19/1999 | CA2319173A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors |
| 08/19/1999 | CA2318966A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors |
| 08/18/1999 | EP0935465A1 Novel substituted imidazole compounds |
| 08/18/1999 | EP0935464A1 Inhibitors of farnesyl-protein transferase |
| 08/18/1999 | CN1226254A Method and composition useful for inhibition of vasculogenesis of alpha, beta medium |
| 08/17/1999 | US5939583 Antiarthritic agents; bone, cardiovascular, brain, nervous system disorders; antitumor and antimetastasis agents |
| 08/17/1999 | US5939432 Thiophenes useful for modulating the adenosine receptor |
| 08/17/1999 | US5939413 Tachykinin mediated diseases in humans for respiratory system disorders like asthma, bronchitis, rhinitis or eye diseases or skin disorders |
| 08/17/1999 | US5939411 Piperidine derivatives substituted at position 4 with new functions other than those described previously have a high affinity for neurokinin receptors and are useful for treatment of substance p and neurokinin dependent pathologies |
| 08/17/1999 | US5939298 Isolated polynucleotide segment having amino acid sequence homology to a known haemophilus influenzae phenylalanyl trna synthetase (alpha-subunit)protein; can be used to screen for antibacterial compounds |
| 08/17/1999 | CA2179008C 5-(2-imidazolinylamino)benzimidazole derivatives, their preparation and their use as alpha-2 adrenoceptor agonists |
| 08/12/1999 | WO1999040085A1 Benzofuran-4-carboxamides and their therapeutic use |
| 08/12/1999 | WO1999040083A2 Bifunctional tryptase inhibitors |